Meet the Experts

James is a highly accomplished commercial strategist and value creation executive with over 20 years of client and full-service agency and consulting experience. He has been directly responsible for managing brands or servicing clients across a variety of healthcare verticals, including pharmaceuticals, specialty pharmaceuticals and hospital and institutional products. Areas of expertise include strategy development, brand and channel marketing, market access, patient support services and market research methodology. He has a proven record of success developing profitable HCP, payer and patient strategies and solutions.

Thought Leadership

Market Access
- Case Study: Value-Based Contracting Strategy and Playbook
  We helped our major pharmaceutical client equip it organization to offer value-based contracts to support access for a new specialty drug. Read the case study.
- Case Study: Reimbursement Strategy for Ophthalmic Insert
  Discover how our tailored reimbursement strategy propelled a small biotech's innovative ophthalmic product to exceed launch forecasts by 60% in patient treatment.
- Case Study: Communicating Value to Payers for New Auto-Immune Product
  We helped a biopharma company design a compelling payer value story presentation for its new auto-immune product
- Article: Are you prepared for the Medicaid AMP cap removal starting January 1, 2024?
  Currently, Medicaid rebates paid by drug manufacturers are capped at the quarterly Average Manufacturer’s Price (AMP) for each drug/biologic. The removal of the cap means ...
- Article: Fed-Up Hospitals are Starting Their Own Drug Company to Lower Generic Drug Prices
  Read the article about the cost and supply challenges leading to Hospitals needing to start their own drug companies to lower generic drug prices.
- White Paper: Inflation Reduction Act Impacts: Navigating the New Landscape
  The IRA will make many improvements to the Medicare program overall, and many on the pharmaceutical side have been mainly focused on preparing for the Medicare Drug Price Negotiation Program. Download this paper to understand the current timelines and guidance.
- Article: Inflation Reduction Act Impacts
  Uncover how the Inflation Reduction Act revolutionizes Medicare & drug prices. Stay ahead with Herspiegel's insights. Read now.
- White Paper: Pre-approval Information Exchange Playbook
  Discover how to tailor product launches effectively with our Archetype Playbook. Master your market strategy now.
- Article: 5 Ways the Build Back Better Act Will Reduce Costs
  Explore 5 key strategies the Build Back Better Act employs to cut drug costs. Essential insights for pharma strategy. Click to learn more.